Testing effectiveness (Phase 2)Ended earlyNCT00154427
What this trial is testing
Use of Activated Recombinant Human Factor VII in Cardiac Surgery
Who this might be right for
Acquired Bleeding DisorderCardiac Surgery Requiring Cardiopulmonary Bypass
Novo Nordisk A/S 172